Results 191 to 200 of about 43,310 (310)

Clinical Strategies to Enhance the Efficacy of Nicotine Replacement Therapy for Smoking Cessation: A Review of the Literature

open access: green, 2013
Matthew J. Carpenter   +6 more
openalex   +2 more sources

An Observational Study of Nicotine Replacement Therapy Availability Through Pharmacist Prescribing in the California Central Valley. [PDF]

open access: yesTob Use Insights
Halliday DM   +6 more
europepmc   +1 more source

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. [PDF]

open access: yesCochrane Database Syst Rev, 2023
Theodoulou A   +8 more
europepmc   +1 more source

First‐in‐Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1617, a Cathepsin‐S Inhibitor, in Healthy Adult Subjects

open access: yesClinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT ASP1617 is a novel, highly selective inhibitor of cathepsin‐S, an important protease for antigen peptide loading onto major histocompatibility complex class II molecules. Preclinically, ASP1617 prevented progression of lupus‐like glomerulonephritis in an NZB/W F1 mouse model of systemic lupus erythematosus.
Tomoki Kojima   +9 more
wiley   +1 more source

Characterising the Periodontal Granulation Tissue Using scRNAseq

open access: yesJournal of Clinical Periodontology, Volume 53, Issue 2, Page 308-320, February 2026.
ABSTRACT Aim To investigate the cellular composition and molecular mechanisms of periodontal granulation tissue formation using single‐cell RNA sequencing (scRNA‐seq), aiming to enhance the understanding of periodontal disease pathogenesis and identify potential targets for regenerative therapies.
Wentao Zhu   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy